ADG20

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19NCT04805671IVVDPhase 2, Phase 3Terminated2022-02-10Actual
Evaluation of ADG20 for the Prevention of COVID-19NCT04859517IVVDPhase 2, Phase 3Terminated2022-11-04Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.